As the Philippines deals with the COVID-19 pandemic, Novartis Healthcare Philippines is taking concrete steps to help ensure sustained supply of essential life-saving medicines to patients and support the country’s COVID-19 response led by the Department of Health (DOH).
“Our main thrust is to protect our frontline health workers and support the expansion of the country’s treatment and testing capacity,” said Jugo Tsumura, Country President & Managing Director, Novartis Healthcare Philippines.
To help expand the country’s COVID-19 testing capacity, Novartis donated PHP19.3M to the Philippine General Hospital (PGH) Medical Foundation for the purchase of locally-produced COVID-19 test kits.
“PGH is waging war on COVID-19. The Novartis support for COVID-19 testing is valuable intelligence in this war. PGH is the biggest COVID-19 referral hospital in the country. To date, PGH has served more than 600 COVID-19 patients and over 3,000 patients with COVID-19 related conditions,” said PGH Director and PGH Medical Foundation Inc. Board of Trustee member Dr. Gerardo Legaspi.
To support the country’s COVID-19 treatment capacity, Novartis and its generics and biosimilars division Sandoz donated a substantial volume of hydroxychloroquine (HCQ) to the Philippine Government in response to the DOH request for a potential treatment for about 1,000 hospitalized patients with moderate to severe COVID-19.
Sandoz is also donating a year’s supply of medicines to the East Avenue Medical Center and other hospitals through the Philippine Red Cross, which will benefit almost 10,000 patients with infections and 6,000 patients with hypertension.